Fig. 2From: Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetesTornado diagram of one-way sensitivity analysis (percentage changes in the ICER from base-case), Acronyms; Met-metformin, DPP-4i-dipeptidyl peptidase-4 inhibitor, SU-sulfonylureaBack to article page